More than 70 mothers were named as complainants representing their children who received shots of the anti-dengue vaccine with brand name Dengvaxia, manufactured by Sanofi Pasteur. Headlines ( Article MRec ), pagematch: 1, sectionmatch: 1Section 3 (e) of RA 3019 prohibits public officials from giving unwarranted benefit, advantage or preference to a private party, or from causing any party, including the government, undue injury. Section 3 (g) meanwhile, prohibits public officials from entering into a contract or transaction grossly disadvantageous to the government. During the recent Senate hearing on the Dengvaxia controversy, former Health undersecretary Susan Mercado revealed that the FEC was “very much against the use of Dengvaxia” and recommended just a stage-by-stage procurement. The complainants said the SARO was released a few weeks after Aquino and Garin met with the officials of Sanofi Pasteur in Paris, France on December 1.

Source: Philippine Star December 22, 2017 09:45 UTC